Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pressure BioSciences and Sage-N Research to Collaborate

Published: Thursday, March 22, 2012
Last Updated: Thursday, March 22, 2012
Bookmark and Share
Packaging PBI's sample preparation system with Sage-N's software tools will allow mass spectrometry laboratories better access and support to these enabling technologies.

Pressure BioSciences, Inc. and Sage-N Research, Inc. have announced a collaboration to develop software applications on Sage-N's SORCERER™ Integrated Data Appliance platform.

The new software will be designed to work with PBI's patented and enabling pressure cycling technology ("PCT") system, a novel technology platform that is used to extract, among other biomolecules, integral cell membrane and other proteins for subsequent mass spectrometry analysis.

Integral cell membrane proteins are of significant clinical importance due to their roles in cell signal transduction in cancer, membrane transport disorders like Crohn's disease, pathogen invasion such as HIV, and their roles in other diseases and disorders.

Unfortunately, integral cell membrane proteins are traditionally very difficult to extract. In some cases, harsh chemicals are used in the extraction process, causing such severe protein degradation that subsequent proteomic analysis is compromised.

PBI's PCT Platform uses rapid cycles of low and ultra-high pressure to safely and effectively extract proteins from samples (including cell membranes) that are suitable for analysis by analytical methods such as mass spectrometry.

The PCT Platform also provides a high level of automation, speed, and reproducibility in the enzymatic breakdown of proteins. This allows the PCT-enhanced digestion to be completed in under an hour, compared to the standard four to twelve hours.

Richard T. Schumacher, President and CEO of PBI, said: "We plan to seamlessly integrate PBI's front- end PCT Sample Preparation System (instruments and consumables) with Sage-N's SORCERER back- end data reduction software. We expect to offer this bundled platform as an option to stand-alone sample preparation and data reduction methods used currently by the mass spectrometry laboratory. We believe that by bundling these enabling platforms, we will be offering a higher quality, more efficient, and less costly solution than they currently have for sample preparation and data reduction. Since the companies now target an identical market - the mass spectrometry laboratory - we expect to share a number of marketing and selling programs directed at this market going forward. Overall, we believe our new co- marketing program will reduce costs and increase sales for both PBI and Sage-N before the end of 2012."

"Mass spectrometry proteomics continues to evolve from a general-purpose protein identification technology to specialized applications, such as characterization of membrane proteins and detecting novel pathogens," noted David Chiang, Chairman of Sage-N Research.

Chiang continued, "Our SORCERER platform continues to evolve to meet the ever expanding IT needs of mass spectrometry labs by providing advanced companion tools for these applications."

Sage-N Research's SORCERER Integrated Data Appliance platform provides complementary software applications that are customized for each particular sample preparation chemistry.

This results in a semi- automated system for membrane and other protein analysis that can use any modern tandem mass spectrometer and liquid chromatography system.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sage-N Research Gains Rights to Sell SEQUEST Proteomic Search Engine
Sage-N will develop and sell products based on the proteomic search software, which was licensed to Thermo Fisher by the University of Washington.
Tuesday, May 15, 2007
Scientific News
Long Telomeres Associated with Increased Lung Cancer Risk
Genetic predisposition for long telomeres predicts increased lung adenocarcinoma risk.
Expanding the Brain
A team of researchers has identified more than 40 new “imprinted” genes, in which either the maternal or paternal copy of a gene is expressed while the other is silenced.
Identifying a Key Growth Factor in Cell Proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study Uncovers Target for Preventing Huntington’s Disease
Scientists from Cardiff University believe that a treatment to prevent or delay the symptoms of Huntington’s disease could now be much closer, following a major breakthrough.
The Genetic Roots of Adolescent Scoliosis
Scientists at the RIKEN Center for Integrative Medical Sciences in collaboration with Keio University in Japan have discovered a gene that is linked to susceptibility of Scoliosis.
A Gene-Sequence Swap Using CRISPR to Cure Haemophilia
For the first time chromosomal defects responsible for hemophilia have been corrected in patient-specific iPSCs using CRISPR-Cas9 nucleases
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
Understanding the Molecular Origin of Epigenetic Markers
Researchers at IRB Barcelona discover the molecular mechanism that determines how epigenetic markers influence gene expression.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!